What Researchers Did
Researchers non-invasively quantified the dermal vasoconstrictive response to hyperbaric oxygen (HBO2) therapy using laser-Doppler flowmetry (LDF) in eight healthy volunteers.
What They Found
They found that dermal microvascular perfusion (flux) continuously decreased during HBO2, dropping to 76.5% at 2.5 atm abs, 50.6% at 1.95 atm abs, and 37% after decompression. Skin temperature also significantly fell below baseline during and after HBO2 exposure, indicating reduced dermal microcirculation and temperature disproportionate to inspired oxygen levels.
What This Means for Canadian Patients
Canadian patients undergoing hyperbaric oxygen therapy may experience reduced blood flow and temperature in their skin, which could impact wound healing or tissue oxygenation. Clinicians should consider these physiological changes when monitoring patients receiving HBO2, especially for conditions where dermal perfusion is critical.
Canadian Relevance
This study has no specific Canadian connection or relevance as indicated by the study metadata.
Study Limitations
A key limitation is the small sample size of only eight healthy volunteers, which may not fully represent diverse patient populations.